Skip to main content
OpenTrials
Completed

NCT Number: NCT02039232

Safety and Efficacy of the CarboFix Pedicle Screw System

The purpose of this study is to evaluate the safety and efficacy of CarboFix' Pedicle Screw System in the lumbar spine.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hillel Yafe MC;, Hadera, Israel

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject is 18 years old or older.
  • Confirmation that the physical examination of radiopathy, myelopathy or combination is in correlation with the affected level.
  • Lumbar CT, MRI, or myelography confirms the level of involvement is consistent with the subject's examination.
  • Informed consent given by the subject.

Exclusion criteria

  • Subject is not eligible for fixation with market-available fixation means.
  • Familial history NF2.
  • Acute traumatic spinal injury with or without neurological signs.
  • Metabolic bone disease.
  • History of Paget's disease or other osteodystrophies whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism hyperparathyroidism, Ehrlers-Danlos-syndrome, osteogenesis imperfecta, achondroplasia, tuberculosis.
  • History of mental disorder or current psychiatric treatment.
  • Pregnancy and/or female subjects intending to become pregnant within the expected time frame of the study and/or female subjects of child bearing age who do not use conventional contraceptive methods.
  • Immune deficiency disease.
  • Infection in the location of the operative site, discitis, osteomyelitis, fever and/or leukocytosis (as diagnosed based on the results of CBC and ESR tests).
  • Scoliosis.
  • Treatment with drugs that may interfere with bone metabolism such as:
  • Cumulative dose of 150 mg. of Prednisone or equivalent within the last 6 months.
  • Calcitonin within the past 6 months.
  • Bisphosphonates for 30 days or more within the last 12 months.
  • Bone therapeutic doses of fluoride for 30 days or more within the last 12 months.
  • Bone therapeutic doses of vitamin D or Vitamin D metabolites for 30 days or more within the last 6 months.
  • Treatment by chemotherapy within the last 12 months.
  • Lack of willingness to make a commitment to return for required follow up visits.
  • Drug and/or alcohol abuse.
  • Morbid obesity.
  • Metal allergies.
  • Recent use of other investigational drugs or devices (within the past 30 days).

Treatment and study plan

Pedicle screw system

Device

Primary outcomes

  1. Fusion success

    Time frame: 6 months post-operation

Sponsors and collaborators

Lead sponsor

CarboFix Orthopedics Ltd.

Industry

Registry information

Official study title

CarboFix Pedicle Screw System

Important dates

Study start
2014
Primary completion
2017
Study completion
2018
First posted
Jan 17, 2014
Registry last updated
Apr 17, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.